The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
1 Year | 5 Year | 5 Year Annualized | Since IPO | |
---|---|---|---|---|
LFMD | +39.14% | +4.24% | +0.83% | +64% |
S&P | +14.5% | +93.32% | +14.09% | +2,411% |
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded in 1987 and is headquartered in New York, NY.
Q2 2025 | YOY Change | |
---|---|---|
Revenue | $62.22M | 22.8% |
Gross Profit | $51.56M | 20.2% |
Gross Margin | 82.86% | -1.8% |
Market Cap | $619.00M | 0.0% |
Market Cap / Employee | $1.84M | 0.0% |
Employees | 336 | 44.8% |
Net Income | -$1.57M | 77.0% |
EBITDA | $1.92M | 147.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
Q2 2025 | YOY Change | |
---|---|---|
Net Cash | $36.23M | 1.5% |
Accounts Receivable | $7.33M | 29.3% |
Inventory | 3.3 | 57.8% |
Q2 2025 | YOY Change | |
---|---|---|
Long Term Debt | $9.55M | -32.4% |
Short Term Debt | $12.50M | 87.1% |
Q2 2025 | YOY Change | |
---|---|---|
Return On Assets | -8.63% | 38.7% |
Return On Invested Capital | -711.01% | 0.0% |
Q2 2025 | YOY Change | |
---|---|---|
Free Cash Flow | $7.84M | 101.2% |
Operating Free Cash Flow | $8.64M | 90.3% |
Metric | Q1 2025 | Q2 2025 | YoY Change | ||
---|---|---|---|---|---|
Price to Book | -41.84 | -254.58 | - | ||
Price to Sales | 1.14 | 0.98 | 1.06 | 2.46 | 54.98% |
Price to Tangible Book Value | -10.76 | -32.17 | - | ||
Price to Free Cash Flow TTM | 12.82 | 16.18 | 22.88 | 40.91 | 80.06% |
Enterprise Value to EBITDA | -98.40 | 56.22 | 46.27 | 309.31 | -559.29% |
Free Cash Flow Yield | 7.8% | 6.2% | 4.4% | 2.4% | -44.46% |
Total Debt | $25.14M | $25.10M | $25.10M | $22.05M | 5.95% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.